Glucagon-like peptide-1 receptor agonists and related incretin therapies in dermatology
Patient selection and shared decision-making.
From the abstractIt reviews the dermatology-relevant adverse effects that patients most often notice, including facial volume loss, hair shedding, and gastrointestinal intolerance, along with a monitoring approach suited to the dermatology visit. Throughout, it argues that shared decision-making offers a useful framework for an area where the evidence is still evolving and where treatment can reshape how patients look and feel.
Ndubisi S, Lio PClinics in Dermatology